Teelken A - Search Results

1

Plasma S100beta and NSE levels and progression in multiple sclerosis.

Koch M, Mostert J, Heersema D, Teelken A, De Keyser J. Koch M, et al. Among authors: teelken a. J Neurol Sci. 2007 Jan 31;252(2):154-8. doi: 10.1016/j.jns.2006.11.012. Epub 2006 Dec 21. J Neurol Sci. 2007. PMID: 17187827

2

Oxidative stress in serum and peripheral blood leukocytes in patients with different disease courses of multiple sclerosis.

Koch M, Ramsaransing GS, Arutjunyan AV, Stepanov M, Teelken A, Heersema DJ, De Keyser J. Koch M, et al. Among authors: teelken a. J Neurol. 2006 Apr;253(4):483-7. doi: 10.1007/s00415-005-0037-3. Epub 2005 Nov 14. J Neurol. 2006. PMID: 16283096

3

Peripheral blood leukocyte NO production and oxidative stress in multiple sclerosis.

Koch M, Mostert J, Arutjunyan A, Stepanov M, Teelken A, Heersema D, De Keyser J. Koch M, et al. Among authors: teelken a. Mult Scler. 2008 Mar;14(2):159-65. doi: 10.1177/1352458507082075. Epub 2007 Oct 17. Mult Scler. 2008. PMID: 17942516

4

Plasma homocysteine levels in multiple sclerosis.

Ramsaransing GS, Fokkema MR, Teelken A, Arutjunyan AV, Koch M, De Keyser J. Ramsaransing GS, et al. Among authors: teelken a. J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):189-92. doi: 10.1136/jnnp.2005.072199. J Neurol Neurosurg Psychiatry. 2006. PMID: 16421120 Free PMC article.

5

Plasma lipid peroxidation and progression of disability in multiple sclerosis.

Koch M, Mostert J, Arutjunyan AV, Stepanov M, Teelken A, Heersema D, De Keyser J. Koch M, et al. Among authors: teelken a. Eur J Neurol. 2007 May;14(5):529-33. doi: 10.1111/j.1468-1331.2007.01739.x. Eur J Neurol. 2007. PMID: 17437612

6

Cerebrospinal fluid oligoclonal bands and progression of disability in multiple sclerosis.

Koch M, Heersema D, Mostert J, Teelken A, De Keyser J. Koch M, et al. Among authors: teelken a. Eur J Neurol. 2007 Jul;14(7):797-800. doi: 10.1111/j.1468-1331.2007.01859.x. Eur J Neurol. 2007. PMID: 17594338

7

Peripheral blood leukocyte NO production in MS patients with a benign vs progressive course.

Ramsaransing GS, Teelken A, Arutjunyan AV, De Keyser J. Ramsaransing GS, et al. Among authors: teelken a. Neurology. 2004 Jan 27;62(2):239-42. doi: 10.1212/01.wnl.0000103239.72937.ad. Neurology. 2004. PMID: 14745060

8

AMPA antagonist ZK200775 in patients with acute ischemic stroke: possible glial cell toxicity detected by monitoring of S-100B serum levels.

Elting JW, Sulter GA, Kaste M, Lees KR, Diener HC, Hommel M, Versavel M, Teelken AW, De Keyser J. Elting JW, et al. Among authors: teelken aw. Stroke. 2002 Dec;33(12):2813-8. doi: 10.1161/01.str.0000043823.37955.fb. Stroke. 2002. PMID: 12468775 Clinical Trial.

9

Comparison of serum S-100 protein levels following stroke and traumatic brain injury.

Elting JW, de Jager AE, Teelken AW, Schaaf MJ, Maurits NM, van der Naalt J, Sibinga CT, Sulter GA, De Keyser J. Elting JW, et al. Among authors: teelken aw. J Neurol Sci. 2000 Dec 1;181(1-2):104-10. doi: 10.1016/s0022-510x(00)00442-1. J Neurol Sci. 2000. PMID: 11099719

10

Insulin-like growth factor system in serum and cerebrospinal fluid in patients with multiple sclerosis.

Wilczak N, Schaaf M, Bredewold R, Streefland C, Teelken A, De Keyser J. Wilczak N, et al. Among authors: teelken a. Neurosci Lett. 1998 Dec 4;257(3):168-70. doi: 10.1016/s0304-3940(98)00829-5. Neurosci Lett. 1998. PMID: 9870347

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

56 results

Search Page

Filters